RA Capital Management - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$658,000
-59.8%
285,0000.0%0.01%
-70.0%
Q3 2020$1,636,000
-22.1%
285,0000.0%0.03%
-26.8%
Q2 2020$2,100,000285,0000.04%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$5,06820.50%
Madison Avenue Partners, LP 3,648,509$14,010,2751.99%
CHI Advisors LLC 864,822$3,320,9161.32%
EcoR1 Capital, LLC 6,117,400$23,490,8160.79%
Rubric Capital Management LP 5,445,910$20,912,2940.78%
BVF INC/IL 6,851,051$26,308,0360.71%
Artal Group S.A. 2,500,000$9,6000.41%
DCF Advisers, LLC 30,430$116,8510.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 458,700$1,761,4080.04%
ACADIAN ASSET MANAGEMENT LLC 1,701,228$6,5310.03%
View complete list of OVID THERAPEUTICS INC shareholders